America First Multifamily (NASDAQ:ATAX) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.57 by 7.02 percent. This is a 3.64 percent decrease over earnings of $0.55 per share from the same period last year.
Earnings Outlook For Nektar Therapeutics
Nektar Therapeutics (NASDAQ:NKTR) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement.
Analysts estimate that Nektar Therapeutics will report an earnings per share (EPS) of $-0.81.